Loading...

PE anti-mouse CD80 Antibody

Pricing & Availability
Clone
16-10A1 (See other available formats)
Regulatory Status
RUO
Other Names
B7-1, B7, Ly-53
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
16-10A1_PE_032309.jpg
Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with 16-10A1 PE
  • 16-10A1_PE_032309.jpg
    Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with 16-10A1 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
104707 50 µg 88€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
104708 200 µg 235€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD80 is a 60 kD highly glycosylated protein. It is a member of the Ig superfamily and is also known as B7-1, B7, and Ly-53. CD80 is constitutively expressed on dendritic cells and monocytes/macrophages, and inducibly expressed on activated B and T cells. The ligation of CD28 on T cells with CD80 and CD86 (B7-2) on antigen presenting cells (such as dendritic cells, macrophages, and B cells) elicits co-stimulation of T cells resulting in enhanced cell activation, proliferation, and cytokine production. CD80 appears to be expressed later in the immune response than CD86. CD80 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Reported Reactivity
Dog
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
CHO cell line transfected with mouse B7 (CD80)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation2, in vitro and in vivo blocking of CTLA-4 Ig to CD80 by blocking costimulation of T cells by activated B cells2-4, and immunohistochemical staining of acetone-fixed frozen sections1,4. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104747-104752).

Application References

(PubMed link indicates BioLegend citation)
  1. Harlan DM, et al. 1994. P. Natl. Acad. Sci. USA 91:3137. (IHC)
  2. Razi-Wolf Z, et al. 1992. P. Natl. Acad. Sci. USA 89:4210. (Block, IP)
  3. Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block)
  4. Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC)
  5. Ma XT, et al. 2006. Cancer Res. 66:1169.
  6. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC)
  7. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  8. Turnquist HR, et al. 2007. J. Immunol. 178:7018.
  9. Misra RS, et al. 2010. J. Exp Med. 207:1775. PubMed
  10. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  11. Philipsen L, et al. 2013. Mol Cell Proteomics. 12:2551. PubMed
Product Citations
  1. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  2. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  3. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  4. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  5. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  6. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  7. Liu M, et al. 2022. Cells. 11: . PubMed
  8. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  9. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  10. Han J, et al. 2023. Front Microbiol. 13:1067725. PubMed
  11. Sohn HS, et al. 2022. Sci Adv. 8:eabo5284. PubMed
  12. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  13. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  14. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  15. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  16. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  17. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  18. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  19. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  20. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  21. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  22. Wang X, et al. 2023. Stem Cell Rev Rep. . PubMed
  23. Wang, Y., Zhu, M., et al. 2025. J Inflamm Res. 18(0),14113-14129. PubMed
  24. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  25. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  26. Rozanski C, et al. 2011. J Exp Med. 208:1435. PubMed
  27. Mulder R, et al. 2017. Front Immunol. 1.464583333. PubMed
  28. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  29. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  30. Wei H, et al. 2021. Malar J. 20:89. PubMed
  31. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  32. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  33. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  34. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  35. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  36. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  37. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  38. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  39. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  40. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  41. Wu J, et al. 2021. Mol Med Rep. 23:. PubMed
  42. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  43. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  44. Bhattacharjee P, et al. 2018. Sci Rep. 13:e0199785. PubMed
  45. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  46. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  47. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  48. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  49. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  50. Tsukasaki M, et al. 2020. Cell Reports. 32(10):108124. PubMed
  51. Zhang F, et al. 2017. Mol Immunol. 10.1016/j.molimm.2017.06.019. PubMed
  52. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  53. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  54. Coe D, et al. 2022. JCI Insight. 7:. PubMed
  55. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  56. Florêncio KGD, et al. 2022. Front Immunol. 13:941757. PubMed
  57. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  58. Guo L, et al. 2021. Vaccines (Basel). 9:. PubMed
  59. Ganesan R, et al. 2020. FASEB J. 34:15888. PubMed
  60. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  61. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  62. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  63. Xie Z, et al. 2018. J Am Heart Assoc. 7:e007442. PubMed
  64. Matundan H, et al. 2019. J Virol. 93. PubMed
  65. Wong E, et al. 2012. J Immunol. 189:5667. PubMed
  66. White C, et al. 2015. J Immunol. 194:697. PubMed
  67. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  68. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  69. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  70. Vogel A, et al. 2022. STAR Protoc. 3:101653. PubMed
  71. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  72. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  73. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  74. Marshall N, et al. 2012. Cancer Res. 72:581. PubMed
  75. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  76. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  77. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  78. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  79. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  80. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  81. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  82. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  83. Kelly SH, et al. 2021. ACS Biomater Sci Eng. 7:1876. PubMed
  84. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  85. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  86. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  87. Izumi G, et al. 2021. Nat Commun. 12:5029. PubMed
  88. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  89. Li J, et al. 2020. Development. :. PubMed
  90. Wang X, et al. 2021. EMBO J. 40:e105926. PubMed
  91. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  92. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  93. Simmons D, et al. 2012. J Immunol. 188:3116. PubMed
  94. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  95. Feng S, et al. 2021. Exp Ther Med. 21:20. PubMed
  96. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  97. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  98. Kelly SH, et al. 2021. Adv Healthc Mater. 10:e2001614. PubMed
  99. Piñón-Zárate G, et al. 2022. Molecules. 27:. PubMed
  100. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  101. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  102. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  103. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  104. Tateishi R, et al. 2015. PLoS One. 10: e0141650. PubMed
  105. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  106. Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
  107. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  108. Zhang X, et al. 2021. Front Pharmacol. 12:706748. PubMed
  109. Kadir NA, et al. 2020. Pathogens. 9:00. PubMed
  110. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  111. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  112. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  113. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  114. Wang Y, et al. 2020. Vaccines (Basel). 8:. PubMed
  115. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  116. Lin YC, et al. 2020. Mol Med Rep. 22:4909. PubMed
  117. Jeisy-Scott V, et al. 2012. J Virol. 86:10988. PubMed
  118. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  119. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
RRID
AB_313128 (BioLegend Cat. No. 104707)
AB_313129 (BioLegend Cat. No. 104708)

Antigen Details

Structure
Ig superfamily, 60 kD
Distribution

Macrophages, activated B cells and T cells, dendritic cells

Function
T cell costimulation
Ligand/Receptor
CD28 (stimulatory), CD152(CTLA4) (inhibitory)
Cell Type
B cells, Dendritic cells, Macrophages, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Linsley PS, et al. 1991. J. Exp. Med. 174:561.
3. Salomon B, et al. 2001. Annu. Rev. Immunol. 19:225.

Gene ID
12519 View all products for this Gene ID
UniProt
View information about CD80 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD80 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse CD80 16-10A1 FC
Purified anti-mouse CD80 (Maxpar® Ready) 16-10A1 FC,CyTOF®
APC/Fire™ 750 anti-mouse CD80 16-10A1 FC
Brilliant Violet 711™ anti-mouse CD80 16-10A1 FC
Brilliant Violet 510™ anti-mouse CD80 16-10A1 FC
TotalSeq™-A0849 anti-mouse CD80 16-10A1 PG
TotalSeq™-C0849 anti-mouse CD80 16-10A1 PG
Ultra-LEAF™ Purified anti-mouse CD80 16-10A1 FC,Block,IHC-F,IP
Alexa Fluor® 594 anti-mouse CD80 16-10A1 IHC-F
Biotin anti-mouse CD80 16-10A1 FC
FITC anti-mouse CD80 16-10A1 FC
PE anti-mouse CD80 16-10A1 FC
Purified anti-mouse CD80 16-10A1 FC,Block,IHC-F,IP
PE/Cyanine5 anti-mouse CD80 16-10A1 FC
APC anti-mouse CD80 16-10A1 FC
Alexa Fluor® 488 anti-mouse CD80 16-10A1 FC
Alexa Fluor® 647 anti-mouse CD80 16-10A1 FC,IHC-F
PerCP/Cyanine5.5 anti-mouse CD80 16-10A1 FC
Pacific Blue™ anti-mouse CD80 16-10A1 FC
Brilliant Violet 421™ anti-mouse CD80 16-10A1 FC,IHC-F
Brilliant Violet 605™ anti-mouse CD80 16-10A1 FC
Brilliant Violet 650™ anti-mouse CD80 16-10A1 FC
PE/Cyanine7 anti-mouse CD80 16-10A1 FC
TotalSeq™-B0849 anti-mouse CD80 Antibody 16-10A1 PG
PE/Fire™ 640 anti-mouse CD80 16-10A1 FC
Spark NIR™ 685 anti-mouse CD80 16-10A1 FC
Spark Red™ 718 anti-mouse CD80 (Flexi-Fluor™) 16-10A1 FC
Spark Blue™ 574 anti-mouse CD80 (Flexi-Fluor™) 16-10A1 FC
Spark PLUS B550™ anti-mouse CD80 Antibody 16-10A1 FC
Spark Red™ 718 anti-mouse CD80 16-10A1 FC
Go To Top Version: 2    Revision Date: 02/18/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account